Skip to main content
The Canadian Journal of Plastic Surgery logoLink to The Canadian Journal of Plastic Surgery
. 2004 Winter;12(4):205–209. doi: 10.1177/229255030401200409

Severe myositis ossificans in a paraplegic trauma patient: Influence in pressure sore management

Wendy Lynne Parker 1, Jacqueline C Hodge 2, Marie-Lucie Lessard 3,
PMCID: PMC3792824  PMID: 24115898

Abstract

Myositis ossificans (MO) is a benign, progressive, ossifying lesion that displays a characteristic zonal histological appearance. MO traumatica is a localized form of heterotopic bone formation, associated with repetitive micro- and/or macrotrauma in the majority of cases. The importance of imaging to differentiate MO from sarcomatous change and to determine maturity of the lesion is identified because suboptimal operative intervention on immature MO inevitably results in recurrence. A severe case of MO in a 24-year-old paraplegic man with chronic bilateral greater trochanteric pressure sores is presented, and the importance of the MO in the etiology and treatment of this case is discussed. An extensive review of the literature is included and integrated.

Keywords: Heterotopic ossification, Myositis ossificans, Paraplegic, Pressure sore


A 24-year-old trauma patient, paraplegic secondary to a gunshot wound at the T5 level, was referred to the Plastic Surgery Division of the McGill University Hospital Center with grade IV bilateral trochanteric pressure sores. During the investigation, the presence of severe, left-sided pelvic myositis ossificans (MO) resulting in a fixed flexion contracture of the hip was noted. The patient had severe pain and spasm on leg extension and was unable to sleep or rest in a supine position. The radiological findings were consistent with MO. It was clear that this underlying problem had to be addressed simultaneously to provide definitive treatment of the trochanteric pressure sores. A review of the literature and details of the investigation of this specific case are provided.

LITERATURE REVIEW

MO can be viewed as four distinct clinical entities, determined by etiology, as outlined by Steiner et al (1): MO traumatica, MO progressiva, MO associated with muscle immobility or degenerative change, and pseudomalignant MO. The original description of heterotopic bone formation associated with spinal cord injury was given in 1918 by Dejerine and Gillier, who noted it in 48% of the paraplegic and quadriplegic patients they investigated (2). Now, heterotopic ossification around the hip is a well-recognized complication of spinal cord injury, the incidence of which is routinely reported to be 15% to 20% (2). Proposed theories for the development of these various forms of MO include implantation of periosteum into the muscle, escape of osteogenic cells from the periosteum, ossification of a hematoma and metaplasia of connective tissue cells (3). Men and women are equally affected, and 75% are younger than 30 years of age. MO can be classified into four clinical and radiographical stages from the onset of pain (Table 1) (46). Marked zonation becomes radiographically apparent as the lesion matures, and can be correlated histologically (Table 2) (6).

TABLE 1.

Staging classification of myositis ossificans

Stage Maturity Clinical symptoms Radiological findings
I Up to 3 weeks Fever and ESR, mild local soft tissue swelling, lack of muscle stretch None
II 3 to 8 weeks Edema, definitive soft tissue mass Early calcification
III 8 to 12 weeks Firm mobile mass, often nontender Marked peripheral calcification
IV 12 weeks to 8 months Possible shrinkage of lesion Zonation to variable findings

ESR Increased erythrocyte sedimentation rate

TABLE 2.

Zonation phenomenon of myositis ossificans correlated with histology

Zone Location Histological findings
I Central Mitotic activity present, highly cellular, variable cell size and shape
II Intermediate Immature osteoma
III Peripheral Mature bone with collagenous fibrous stroma

Diagnosis and imaging

The accurate diagnosis of this lesion is important to distinguish MO from sarcomatous change. Histologically, this can be confusing; therefore, relying on biopsy to make a diagnosis is not warranted. In addition, this lesion has been mistaken for hematomas, infection or abscess, benign neoplasms and primary malignant lesions such as malignant mesenchymomas or metastatic MO (7). On serial x-rays following a trauma, peripheral ossification gradually develops, but may take six to eight weeks to be detectable and a differential diagnosis remains. Thus, x-ray results should be correlated with serial nuclear scans. On computed tomography (CT) scan, MO has a characteristic well-defined shell of bone. Although CT clearly defines the location of the lesion and its extent and invasion into local tissues, CT should be reserved for the evaluation of mature lesions because it is a more costly examination than nuclear imaging (1,8).

Nuclear imaging, three-phase bone scans in particular, is the standard in determining lesion maturity. Active or immature MO lesions demonstrate increased radiotracer activity on arterial, blood pool and delayed phases. As the MO lesion matures, it becomes inactive, displaying increased activity on only the third or delayed phase of the bone scan (8). Ancillary radiological exams, most often CT, are required because of the poor spatial resolution of nuclear imaging that fails to give precise details on lesion size, demarcation and surrounding anatomical structures. Despite this drawback, no other imaging technique has been found to be superior to nuclear scanning in its ability to determine lesion maturity.

Complications

Once definitively diagnosed as MO, heterotopic bone formation may present with complications – those directly related to the lesion and those related to the treatment of MO. MO runs a relatively benign course in 80% of patients; however, the lesion itself can result in chronic severe pain and decreased range of motion of an involved joint or muscle. In the 20% of cases where significant loss of motion develops, ankylosis is noted in 10% (9). Several cases of osteosarcoma arising within MO have been presented in the literature (1,10). In addition, MO can lead to peripheral neuropathies and, in one case, brachial plexopathy (11). Although infrequently, acute fractures through pre-existing, quiescent, heterotopic bone may occur (12).

Osteomyelitis has been considered both a complication of MO as well as a predisposing factor (2). Similarly, pressure sores may present after MO is established or incite the lesion (2,13). Moreover, early aggressive operative resection of the lesion ultimately results in recurrence and, often, progression of MO.

The following case report concerns a paraplegic patient with a severe MO of the left hip being the main etiology of bilateral grade IV trochanteric pressure sores.

CASE PRESENTATION

A 22-year-old man sustained a gunshot wound to the chest, resulting in complete T5 paraplegia. Over the next five years, he had repeated admissions for urosepsis and bilateral osteomyelitis of the hips and was treated with various antibiotic regimens. His condition progressed such that he developed severe flexion contractures of the hips, and ultimately, chronic bilateral greater trochanteric pressure sores that were unresponsive to medical treatment (Figure 1). He was referred to our service for management. His work-up included standard x-rays (Figure 2A), CT (Figure 2B) and nuclear medicine scans (Figure 3), which resulted in a diagnosis of MO.

Figure 1).

Figure 1)

AIn the supine position, the patient demonstrates severe flexion contractures of both hips.BWith the patient in the right lateral decubitus position, the right greater trochanteric pressure sore is evident

Figure 2).

Figure 2)

AAnteroposterior radiograph of the pelvis. The small curvilinear collections of gas bilaterally represent soft tissue ulcers. Exuberant myositis ossificans (MO) explains the relatively increased density and size of the left acetabular/supra-acetabular and left proximal femoral shaft region. The MO partially obscures the left hip joint. A small area of MO is contiguous with the right greater trochanter.BTransaxial computed tomography scan through the hips. A small curvilinear rim of MO lies adjacent to the right greater trochanter. A 2 cm × 1 cm ulcer lies superficial to the MO. At the contralateral (left) hip, a large bony and soft tissue mass sits anterior to the proximal femoral diaphysis. The soft tissue areas represent MO that has not yet ossified. A smaller ulcer, approximately 1 cm × 1 cm, is seen lateral to the peripheral extent of the MO. The pocket of fluid sitting between the left femoral shaft and left ischial tuberosity represents a hip joint effusion. There is no osteolysis or periosteitis at either femora/MO to suggest superimposed osteomyelitis

Figure 3).

Figure 3)

Nuclear medicine scans of the pelvis (bone and gallium).AEvidence of immature myositis ossificans.BandCEvolution of the lesion is seen by the gradual decrease in image intensity over the course of five years.DLesion maturity is suggested by the stabilization of activity of the lesion

Despite this patient’s chronic pain and immobility, surgical treatment was avoided throughout the period of MO immaturity (Figure 2A). It is well accepted that operative intervention at this time leads to recurrence or progression of the lesion. It is likely that this patient’s trochanteric pressure sores were a result of the vicious cycle of inappropriate supine and wheelchair positioning secondary to the hip flexion contracture from the underlying MO.

Once lesion maturity was reached, as documented by nuclear scan (Figure 3D), the MO was surgically resected. Bilateral proximal femorectomy was performed at two independent operative interventions. Initially, the patient was positioned in a left lateral decubitus position and the left hip was approached in the standard fashion for a total hip arthroplasty. Dissection was carried out over the left femur, and the greater trochanter was identified. Of note, an extensive bursa had formed, underlying the site of the chronic ulcer. There was significant heterotopic ossification surrounding primarily the anterior and medial aspects of the femur. The femur was divided at the level just cephalad to the lesser trochanter and disarticulated from the pelvis (Figure 4A). This allowed for better exposure of the medial and anterior MO, which was subsequently resected (Figure 4B). An inferolaterally based gluteus maximus pedicled muscle flap was advanced into the left acetabulum and bony defect (Figure 4C), hemostasis was achieved and three drains were left in situ. The indurated soft tissue surrounding the ulcer was saucerized and the wound was closed primarily (Figure 4D). The patient tolerated the procedure well, and there were no postoperative complications. Postoperatively, the patient was given supplemental magnesium as recommended and was continued on nonsteroidal anti-inflammatory drugs (NSAIDs) until leaving the hospital. A similar procedure was subsequently performed on the right hip, but closure was performed with a right vastus lateralis advancement flap. He was without recurrent trochanteric pressure sores up to two years postsurgery.

Figure 4).

Figure 4)

AThe extent of the surgical defect following myositis ossificans resection. The femoral head has been disarticulated and the distal extent of the femoral resection can be seen.BResected specimen of the left proximal femur and surrounding myositis ossificans.CInferiorly based gluteus maximus flap rotated into the surgical defect.DClosure achieved by direct approximation over suction drains

This case of a paraplegic patient with bilateral trochanteric pressure sores associated with and subsequent to severe hip flexion contracture was challenging. The severe ankylosis of the left hip contributed to his pressure sores because positioning was limited to the right and left lateral decubitus. Supine positioning resulted in extreme discomfort due to the bilateral hip contractures. This fixed flexed position of his hip was attributable to the peripelvic MO. This was confirmed by our investigations and the pathological specimen.

DISCUSSION

Although diagnosis of early MO can be difficult, if it is made, some authors advocate rest, elevation and ice for the affected soft tissue (14,15). However, there has been increased focus on the treatment of more mature lesions, with approaches based on bone physiology and inhibition of hydroxyapatite (HA) formation (16).

One approach has been the use of diphosphonates. However, absorption of diphosphonates is limited; only 1% to 10% is absorbed when administered orally, and a maximum of 50% is absorbed when administered intravenously (17). Moreover, these agents only delay the development of MO, with mineralization ensuing once treatment is withdrawn (18). Magnesium has been shown to inhibit HA formation by adsorbing onto the crystal surfaces and blocking growth sites and, thus, has been used to inhibit heterotopic bone formation with a 75% success rate noted (19). Proteoglycans, aluminum ions, metal citrate complexes, phosphoproteins and serum proteins such as albumin and other globulins have also been shown to inhibit HA formation in vitro, but this is not supported by any clinical trials (16).

NSAIDs, such as indomethacin and ibuprofen, have been shown to decrease the formation of MO and are considered to be prophylactic agents. A review of 12 randomized clinical trials concluded that medium- to high-dose NSAIDs decrease the risk of heterotopic bone formation by 62% following total hip arthroplasty (20).

Local radiotherapy has also been shown to block bone induction by bone morphogenic proteins (BMPs) and therefore has been used as prophylactic treatment for MO. A prospective trial demonstrated that treatment with 200 rads/day of radiation given over five to seven days preoperatively and for one to four days postoperatively following total hip arthroplasty was highly effective in the prevention of both heterotopic ossification and the recurrence after excision of pre-existing lesions (21). Similar results have been reported with postoperative regimens (22,23). In addition, BMPs and MO have also been inhibited by antibody against BMP-4 or via an antagonist noggin, which binds BMP-4 directly, inhibiting ectopic bone formation (24,25).

Operative intervention for immature MO is not warranted. Even for mature lesions, caution is urged and complete excision should be performed, otherwise rapid local recurrence is the rule (14). Surgical excision should be reserved for mature lesions resulting in intractable pain and severe limitation of motion. Shehab et al (9) have recently outlined criteria for recommending surgical removal of heterotopic ossification, including significantly limited range of motion for involved joint (eg, hip should have less than 50% range of motion); absence of local fever, swelling, erythema or other clinical findings of acute heterotopic ossification; normal serum alkaline phosphatase; and return of bone scan findings to normal or near normal, or a sharply decreasing trend followed by steady state for two to three months. The outcome may be further optimized by a combined medical and surgical therapeutic approach.

CONCLUSION

Peripelvic heterotopic ossification is well documented in patients with spinal cord injury, with an incidence reported to be as high as 15%. It is essential to address the MO problem to succeed with the surgical treatment of these associated and secondary pressure sores. The clinician has two responsibilities with regard to managing the patient with MO: to avoid misdiagnosis of a sarcoma, and to determine the maturity of MO.

Imaging studies, rather than biopsy, are the key to both diagnostic work-up and timely intervention. Whereas premature surgery lends itself to inevitable recurrence of MO, delayed intervention may result in sequelae. Moreover, it is important to remember the relatively high risk of developing MO in the paraplegic population. There appears to be a role for both ionizing radiation and NSAIDs in the prevention and recurrence of MO. These modalities should be considered in the plastic surgeon’s armamentarium against the lesion and its potential sequelae in high risk patients, namely, spinal cord injured with spasticity, concurrent infections, pressure sores and ensuing surgical procedures.

REFERENCES

  • 1.Steiner M, Gould AR, Kushner GM, Lutchka B, Flint R. Myositis ossificans traumatica of the masseter muscle: Review of the literature and report of two additional cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997;84:703–7. doi: 10.1016/s1079-2104(97)90376-0. [DOI] [PubMed] [Google Scholar]
  • 2.Tanaka T, Rossier AB, Hassey RW, Ahnberg DS, Treves S. Quantitative assessment of para-osteo-arthropathy and its maturation on serial radionuclide bone images. Radiology. 1977;123:217–21. doi: 10.1148/123.1.217. [DOI] [PubMed] [Google Scholar]
  • 3.Takahashi K, Sato K. Myositis ossificans traumatica of the medial pterygoid muscle. J Oral Maxillofac Surg. 1999;57:451–6. doi: 10.1016/s0278-2391(99)90289-6. [DOI] [PubMed] [Google Scholar]
  • 4.Shirkhoda A, Armin AR, Bis KG, Makris J, Irwin RB, Shetty AN. MR imaging of myositis ossificans: Variable patterns at different stages. J Magn Reson Imaging. 1995;5:287–92. doi: 10.1002/jmri.1880050312. [DOI] [PubMed] [Google Scholar]
  • 5.Tyler JL, Derbekyan V, Lisbona R. Early diagnosis of myositis ossificans with Tc-99m diphosphonate imaging. Clin Nucl Med. 1984;9:256–8. doi: 10.1097/00003072-198405000-00002. [DOI] [PubMed] [Google Scholar]
  • 6.Heinrich SD, Zembo MM, MacEwen GD. Pseudomalignant myositis ossificans. Orthopedics. 1989;12:599–602. doi: 10.3928/0147-7447-19890401-15. [DOI] [PubMed] [Google Scholar]
  • 7.Massengill AD, Seeger LL, Yao L, Mirra JM, Eckardt JJ. Malignant mesenchymoma of the thigh. Skeletal Radiol. 1995;24:301–4. doi: 10.1007/BF00198421. [DOI] [PubMed] [Google Scholar]
  • 8.Kirkpatrick JS, Koman LA, Rovere GD. The role of ultrasound in the early diagnosis of myositis ossificans. A case report. Am J Sports Med. 1987;15:179–81. doi: 10.1177/036354658701500216. [DOI] [PubMed] [Google Scholar]
  • 9.Shehab D, Elgazzar AH, Collier BD. Heterotopic ossification. J Nucl Med. 2002;43:346–53. [PubMed] [Google Scholar]
  • 10.Konishi E, Kusuzaki K, Murata H, Tsuchihashi Y, Beabout JW, Unni KK. Extraskeletal osteosarcoma arising in myositis ossificans. Skeletal Radiol. 2001;30:39–43. doi: 10.1007/s002560000298. [DOI] [PubMed] [Google Scholar]
  • 11.Reavey-Cantwell JF, Garonzik I, Viglione MP, McCarthy EF, Belzberg AJ. A brachial plexopathy due to myositis ossificans. Case report and review of the literature. J Neurosurg. 2001;95:525–8. doi: 10.3171/jns.2001.95.3.0525. [DOI] [PubMed] [Google Scholar]
  • 12.Mestan MA, Bassano JM. Fractured heterotopic bone in myositis ossificans traumatica. J Manipulative Physiol Ther. 2001;24:296–9. doi: 10.1067/mmt.2001.114360. [DOI] [PubMed] [Google Scholar]
  • 13.Hassard GH. Heterotopic bone formation about the hip and unilateral decubitus ulcers in spinal cord injury. Arch Phys Med Rehabil. 1975;56:355–8. [PubMed] [Google Scholar]
  • 14.King JB. Post-traumatic ectopic calcification in the muscles of athlete: A review. Br J Sports Med. 1998;32:287–90. doi: 10.1136/bjsm.32.4.287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Wieder DL. Treatment of traumatic myositis ossificans with acetic acid iontophoresis. Phys Ther. 1992;72:133–7. doi: 10.1093/ptj/72.2.133. [DOI] [PubMed] [Google Scholar]
  • 16.Blumenthal NC. Mechanisms of inhibition of calcification. Clin Orthop. 1989;247:279–89. [PubMed] [Google Scholar]
  • 17.Devogelaer JP. Clinical use of bisphosphonates. Curr Opin Rheumatol. 1996;8:384–91. doi: 10.1097/00002281-199607000-00018. [DOI] [PubMed] [Google Scholar]
  • 18.Bijvoet OL, Nollen AJ, Slooff T, Feith R. Effect of a diphosphonate on para-articular ossification after total hip replacement. Acta Orthop Scand. 1974;45:926–34. doi: 10.3109/17453677408989703. [DOI] [PubMed] [Google Scholar]
  • 19.Ditmar R, Steidl L. The importance of magnesium in orthopaedics VI. The importance of magnesium in the treatment of ectopic calcifications and ossifications. Acta Chir Orthop Traumatol Cech. 1989;56:190–200. [PubMed] [Google Scholar]
  • 20.Neal B, Rodgers A, Dunn L, Fransen M. Non-steroidal anti-inflammatory drugs for preventing heterotopic bone formation after hip arthroplasty. Cochrane Database Syst Rev. 2000;3:CD001160. doi: 10.1002/14651858.CD001160. [DOI] [PubMed] [Google Scholar]
  • 21.Ayers DC, Evarts CM, Parkinson JR. The prevention of heterotopic ossification in high-risk patients by low-dose radiation therapy after total hip arthroplasty. J Bone Joint Surg Am. 1986;68:1423–30. [PubMed] [Google Scholar]
  • 22.Coventry MB, Scanlon PW. The use of radiation to discourage ectopic bone: A nine-year study in surgery about the hip. J Bone Joint Surg Am. 1981;63:201–8. [PubMed] [Google Scholar]
  • 23.Knelles D, Barthel T, Karer A, et al. Prevention of heterotopic ossification after total hip replacement: A prospective, randomized study using acetyl salicylic acid, indomethacin and fractional single dose irradiation. J Bone Joint Surg Br. 1997;79:596–602. doi: 10.1302/0301-620x.79b4.6829. [DOI] [PubMed] [Google Scholar]
  • 24.Reddi AH. Initiation of fracture repair by bone morphogenetic proteins. Clin Orthop. 1998;355:S66–72. doi: 10.1097/00003086-199810001-00008. [DOI] [PubMed] [Google Scholar]
  • 25.Zimmerman LB, De Jesus-Escobar JM, Harland RM. The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell. 1996;86:599–606. doi: 10.1016/s0092-8674(00)80133-6. [DOI] [PubMed] [Google Scholar]

Articles from The Canadian Journal of Plastic Surgery are provided here courtesy of Pulsus Group

RESOURCES